Our Companies

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

Founded by Dr. Niall Armes, Biocrucible is a UK-based company focused on enhancing and accelerating the behavior and kinetics of engineered biological systems. The Company aims to commercialize its proprietary isothermal molecular technology platform in rapid testing settings.

learn more

Graphene-Dx is a consumer-focused, point-of-care rapid diagnostics platform that leverages novel graphene technology to create a new biosensor for real-time detection of biomarkers in a broad range of sample types.

Learn more